determination course of disease of COVID-19 in the primary care setting
ID
Bron
Verkorte titel
Aandoening
acute respiratory tract infection
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The proportion of COVID-19 in patients presenting with CA-ARTI in primary care
Achtergrond van het onderzoek
Rationale: When a new infection emerges, most detailed information about presentation, management and clinical course is obtained from severe and/or hospitalized cases. This is currently also the case for the COVID-19 pandemic. As a consequence, little information is available from patients with mild and/or undiagnosed SARS-CoV-2 infection. These patients often contact primary care providers, either at the practice or by telephone. There is still much uncertainty about who will develop mild or more severe symptoms upon acquiring the infection and who is at risk of severe complications. We will therefore perform a study in primary care with patients presenting with acute respiratory tract infection in 4-8 European countries.
Objective: To generate information on the presentation and management of patients with community-acquired acute respiratory tract infection in primary care during the COVID-19 pandemic, to determine the proportion of these patients infected with SARS-CoV-2, and risk factors for getting COVID-19 and for a complicated course of COVID-19 disease.
Study design: Observational study with patient follow-up.
Study population: Patients aged one year and older, presenting in primary care (either in person, or phone/video), with symptoms of community-acquired acute respiratory tract infection (CA-ARTI) during the COVID-19 pandemic.
Main study parameters/endpoints: The proportion of patients with SARS-CoV-2 infection in patients presenting with CA-ARTI in primary care settings in various European countries, with description of their course of disease (illness days, non-productive days, complications and death).
Doel van het onderzoek
determination course of disease of COVID-19 in the primary care setting
Onderzoeksopzet
follow-up at day 7 and 28
Onderzoeksproduct en/of interventie
none
Algemeen / deelnemers
Alike van der Velden
31 88-756 8511
a.w.vandervelden@umcutrecht.nl
Wetenschappers
Alike van der Velden
31 88-756 8511
a.w.vandervelden@umcutrecht.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
• Male or female aged one year or older;
• Consulting face-to-face, online, or telephoning with symptoms of CA-ARTI (upper and or lower), with symptoms of cough, sore throat and/or rhinitis, or when the GP has another reason to suspect COVID-19;
• Is able and willing to comply with all study requirements;
• Participant or legal guardian(s) of a child is able and willing to give informed consent;
• Availability of a freezer at the practice, patient’s home, or a laboratory location to be reached within 1 hour.
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
• Patients with symptoms of earache only;
• Patients who do not master the national language or are otherwise not able to participate in follow-up procedures;
• Patients who are terminally ill;
• Patients tested positive for SARS-CoV-2 prior to recruitment.
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Toelichting
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL8520 |
CCMO | NL73596.041.20 |